These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37302448)

  • 21. Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel syndrome diagnosed using the Rome IV criteria: a cross-sectional survey during a medical check-up in Japan.
    Otani K; Watanabe T; Takahashi K; Nadatani Y; Ominami M; Fukunaga S; Hosomi S; Kamata N; Tanaka F; Nagami Y; Taira K; Kimura T; Fukumoto S; Fujiwara Y
    BMC Gastroenterol; 2023 May; 23(1):140. PubMed ID: 37138209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.
    Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
    Scand J Gastroenterol; 2015 Jul; 50(7):816-23. PubMed ID: 25636675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irritable bowel syndrome based on Rome IV diagnostic criteria associates with non-motor symptoms of Parkinson's disease.
    Tai YC; Liao PH; Leta V; Lin CH; Chaudhuri KR
    Parkinsonism Relat Disord; 2023 Aug; 113():105496. PubMed ID: 37385160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Organic Colonic Lesions by Colonoscopy in Patients with Irritable Bowel Syndrome Fulfilling Rome III Criteria.
    Sarkar MM; Saha M; Saha BN; Chowdhury MK; Hasan MN; Arefin MS; Tariquzzaman M
    Mymensingh Med J; 2020 Oct; 29(4):914-919. PubMed ID: 33116096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
    Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
    Barberio B; Fairbrass KM; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of alarm symptoms in Rome IV irritable bowel syndrome: A multicenter cross-sectional study.
    Yang Q; Wei ZC; Liu N; Pan YL; Jiang XS; Tantai XX; Yang Q; Yang J; Wang JJ; Shang L; Lin Q; Xiao CL; Wang JH
    World J Clin Cases; 2022 Jan; 10(2):563-575. PubMed ID: 35097082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study.
    Barberio B; Yiannakou Y; Houghton LA; Black CJ; Savarino EV; Ford AC
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e89-e101. PubMed ID: 33839276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?
    Ford AC; Talley NJ; Veldhuyzen van Zanten SJ; Vakil NB; Simel DL; Moayyedi P
    JAMA; 2008 Oct; 300(15):1793-805. PubMed ID: 18854541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exocrine Pancreatic Insufficiency is Undiagnosed in Some Patients with Diarrhea-Predominant Irritable Bowel Syndrome Using the Rome IV Criteria.
    Olmos JI; Piskorz MM; Litwin N; Schaab S; Tevez A; Bravo-Velez G; Uehara T; Hashimoto H; Rey E; Sorda JA; Olmos JA
    Dig Dis Sci; 2022 Dec; 67(12):5666-5675. PubMed ID: 35704255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and impact of self-reported irritable bowel symptoms in the general population.
    Van den Houte K; Carbone F; Pannemans J; Corsetti M; Fischler B; Piessevaux H; Tack J
    United European Gastroenterol J; 2019 Mar; 7(2):307-315. PubMed ID: 31080615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.
    Goodoory VC; Guthrie EA; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2023 Feb; 57(3):323-334. PubMed ID: 36544055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.
    Goodoory VC; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2022 Jul; 56(1):110-120. PubMed ID: 35491477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
    J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the United States: Results From a Nationwide Cross-Sectional Study.
    Almario CV; Sharabi E; Chey WD; Lauzon M; Higgins CS; Spiegel BMR
    Gastroenterology; 2023 Dec; 165(6):1475-1487. PubMed ID: 37595647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.
    Goodoory VC; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2023 May; 57(10):1083-1092. PubMed ID: 36914979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Durability of the diagnosis of irritable bowel syndrome based on clinical criteria.
    Adeniji OA; Barnett CB; Di Palma JA
    Dig Dis Sci; 2004 Apr; 49(4):572-4. PubMed ID: 15185859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.